Atlantic Pharmaceuticals Ltd   Report issue

For profit Phase 3
Founded: Atlanta GA United States (2003)
Status: No NME R&D (2003)

Organization Overview

First Clinical Trial
2015
NCT02525523
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Atlantic Pharmaceuticals | Atlantic Pharmaceuticals Ltd

Active Ingredients

Drugs in Phase 3 Trials (1)

alicaforsen (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pouchitis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 1